Silence Therapeutics reported $12.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Autolus Therapeutics Ltd USD 96.76M 3.94M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 12.5M 13.91M Dec/2025